Market Place
Sourcing Support
Apotex`s Generic Ceftaroline Fosamil Receives Approval In US
21 Sep 2021 //
FDA
Global MRSA Drugs Market to Surpass US$ 1.3 Billion by 2026
24 Sep 2019 //
BUSINESSWIRE
AZ bags two extensions in latest CHMP decisions
01 Jul 2019 //
PHARMATIMES
Apotex`s Generic Ceftaroline Fosamil Receives Tentative Approval in US
30 Jan 2019 //
FDA
Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer
04 Jun 2018 //
PRESS RELEASE
FDA Accepts Supplemental New Drug Application for TEFLARO
17 Feb 2016 //
PR NEWSWIRE
Allergan Announces FDA Approval of Updated Label for TEFLARO® (ceftaroline fosamil)
02 Sep 2015 //
PR NEWS WIRE
Actavis Announces FDA Acceptance of sNDA to Expand TEFLARO
04 Feb 2015 //
ACTAVIS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.